Insulet Corporation Wins $452 Million in Landmark Trade Secrets Case Against Rival EOFlow
BOSTON — A federal jury has awarded Insulet Corporation, a leading producer of tubeless insulin pump patches, a groundbreaking $452 million in damages, marking a significant verdict in the realm of trade secret litigation. The decision came after Insulet accused EOFlow Co. Ltd., and several of its associates, of willfully misappropriating its proprietary technology, which has significantly advanced diabetes care management since its FDA approval in 2005. Insulet, known for its Omnipod insulin pumps, argued that EOFlow, a direct competitor founded in 2011, redesigned its insulin patches to mimic the Omnipod after EOFlow hired key … Read more